Inventor · disambiguated record
Song Yang
Also filed as: YANG SONG · YANG SONG I
32 granted patents·25 pending applications·208 citations·filing 2007–2024
96Inventor score
Top patents by PatentIndex Score
57 records- 0197US7495007B2Spiroindolinone derivativesHOFFMANN LA ROCHE·Filed 2007·Granted Feb 24, 2009·37 cites·45 claims
- 0295US8058269B2Oxindole derivativesCHEN LI·Filed 2007·Granted Nov 15, 2011·29 cites·17 claims
- 0394US9458153B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Oct 4, 2016·23 cites·20 claims
- 0493US8076482B23,3′-spiroindolinone derivativesCHEN LI·Filed 2010·Granted Dec 13, 2011·28 cites·4 claims
- 0591US10093671B22-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Oct 9, 2018·14 cites·17 claims
- 0691US9845322B2Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Dec 19, 2017·7 cites·46 claims
- 0791US7776875B2Spiroindolinone derivativesHOFFMANN LA ROCHE·Filed 2008·Granted Aug 17, 2010·20 cites·12 claims
- 0889US7928233B2Spiroindolinone pyridine derivativesHOFFMANN LA ROCHE·Filed 2010·Granted Apr 19, 2011·7 cites·4 claims
- 0988US9637485B26,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted May 2, 2017·9 cites·25 claims
- 1087US11191775B2PAPD5 and PAPD7 inhibitors for treating a hepatitis B infectionHOFFMANN LA ROCHE·Filed 2017·Granted Dec 7, 2021·2 cites·8 claims
- 1185US10053461B2Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Aug 21, 2018·3 cites·21 claims
- 1283US9949966B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Apr 24, 2018·4 cites·21 claims
- 1382US9920049B2Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Mar 20, 2018·5 cites·16 claims
- 1481US11104674B2Tetrahydropyridopyrimidines for the treatment of HBV infectionHOFFMANN LA ROCHE·Filed 2018·Granted Aug 31, 2021·2 cites·33 claims
- 1581US8134001B2Spiroindolinone derivativesDING QINGJIE·Filed 2008·Granted Mar 13, 2012·9 cites·22 claims
- 1680US10336751B2Tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Jul 2, 2019·3 cites·12 claims
- 1780US10150740B26,7-dihydropyrido[2,1-A]phthalazin-2-ones for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Dec 11, 2018·3 cites·15 claims
- 1877US11390604B2Imidazole-pyrazole derivativesHOFFMANN LA ROCHE·Filed 2020·Granted Jul 19, 2022·1 cites·31 claims
- 1976US10196391B2Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Feb 5, 2019·2 cites·12 claims
- 2073US2022096527A1Papd5 and papd7 inhibitors for treating a hepatitis b infectionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2172US12421211B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Granted Sep 23, 2025·0 cites·15 claims
- 2265US11858912B2Heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2022·Granted Jan 2, 2024·0 cites·16 claims
- 2365US2024376073A1Quaternary ammonium cation substituted compounds for the treatment of bacterial infectionsHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2462US2023257354A1Novel heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2561US2023141600A1Imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2661US2023295123A1Novel imidazole-pyrazole derivativesHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2760US2023141403A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2859US2023203047A1Novel imidazopyrazne derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2959US2023234939A1Imidazole-pyrazole derivatives as antibacterialsHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 3059US2023203043A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3158US2022396565A1Novel heterocyclic compoundsHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 3257US2025099478A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 3355US10781201B2Benzimidazole derivative having JNK inhibitory activity and use thereofIUCF HYU ERICA CAMPUS·Filed 2019·Granted Sep 22, 2020·0 cites·5 claims
- 3454US11884628B2Method for synthesizing lactam derivatives without use of catalystUNIV GUIZHOU·Filed 2019·Granted Jan 30, 2024·0 cites·5 claims
- 3554US2023012368A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3653US12459927B2Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 4, 2025·0 cites·16 claims
- 3753US11225482B2Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Jan 18, 2022·0 cites·17 claims
- 3853US2023022724A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 3953US2023017532A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4053US2023011869A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4153US2023272056A1Affinity matured anti-lap antibodies and uses thereofMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 4253US2024116945A1Exatecan-derived topoisomerase-1 inhibitors pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 4352US2024208994A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 4452US2023013602A1Novel imidazopyrazine derivativesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 4552US2024025917A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 4651US2023416227A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 4749US2007213341A1Spiroindolinone derivativesCHEN LI·Filed 2007·Application pending·0 cites
- 4847US10968218B2Tetrahydropyridopyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Apr 6, 2021·0 cites·14 claims
- 4946US11447489B2Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Sep 20, 2022·0 cites·16 claims
- 5044US11124495B2Tetrahydroisoquinolines and terahydronaphthyridines for the treatment of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2017·Granted Sep 21, 2021·0 cites·19 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Song Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →